Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-12-23Clinical Trial Update: DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma [Phase 3]
Phase 3 trial of DCVAC/OvCa with standard of care for relapsed ovarian/fallopian tube/peritoneal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-07-15Clinical Trial Update: Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer [Phase 3]
Phase 3 trial comparing Niraparib-bevacizumab-Dostarlimab vs Niraparib-bevacizumab to standard of care in recurrent ovarian cancer has been …
-
CLINICAL_TRIALS withdrawal · 2020-02-24Clinical Trial Update: Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission [Phase 3]
Phase 3 clinical trial evaluating a vaccine therapy with OPT-821 in ovarian epithelial, fallopian tube, or primary peritoneal cancer was wit…
-
CLINICAL_TRIALS withdrawal · 2019-02-20Clinical Trial Update: Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating metformin hydrochloride with carboplatin and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS withdrawal · 2018-06-15Clinical Trial Update: An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients [NA]
A clinical trial evaluating an exercise intervention to reduce symptoms and improve outcomes for ovarian cancer patients receiving platinum-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-06-06Clinical Trial Update: PET Imaging of Ovarian Carcinoma With 18F-FSPG [EARLY_Phase 1]
A Phase 1 trial evaluating the PET imaging agent 18F-FSPG for ovarian, fallopian tube, and primary peritoneal cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-17Clinical Trial Update: Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan
Olaparib expanded access program for BRCA-mutated platinum-sensitive relapsed high-grade epithelial ovarian cancer in Japan is no longer ava…
-
CLINICAL_TRIALS withdrawal · 2018-05-01Clinical Trial Update: Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
The Phase 1 trial evaluating sirolimus in combination with a vaccine therapy for stage II-IV ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS withdrawal · 2017-11-20Clinical Trial Update: Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating doxorubicin and carboplatin for recurrent ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-10Clinical Trial Update: Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients [Phase 2]
A Phase 2 trial evaluating a carboplatin, eribulin, and veliparib combination in stage IV breast and ovarian cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-18Clinical Trial Update: Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression. [Phase 2]
A Phase 2 trial in recurrent ovarian cancer evaluating two doses of a study drug with low-dose cyclophosphamide after response to platinum-b…
-
CLINICAL_TRIALS withdrawal · 2017-07-13Clinical Trial Update: Toremifene in Treating Patients With Ovarian Cancer [Phase 2]
This clinical trial update reports that the Phase 2 study of toremifene for ovarian cancer sponsored by George Washington University has bee…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating CT-011 and a p53 genetic vaccine for advanced solid tumors was withdrawn; the study encompassed breast cancer, co…
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of DCVax-L vaccination combined with CD3/CD28-costimulated autologous T-cells for recurrent ovarian cancer or primary peri…
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids [NA]
The clinical trial aimed to identify biomarkers for ovarian and endometrial cancers in vaginal fluids, but the study has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS withdrawal · 2017-04-21Clinical Trial Update: N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer [Phase 1]
A Phase 1 trial of intravenous N-acetylcysteine with cisplatin and paclitaxel for ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-23Clinical Trial Update: TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer [Phase 3]
Amgen's TRINOVA-3 Phase 3 trial evaluating AMG 386 with paclitaxel and carboplatin for ovarian, fallopian tube, and peritoneal cancers has b…
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer [Phase 1]
A Phase 1 trial evaluating azacitidine with carboplatin and paclitaxel for newly diagnosed ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-11Clinical Trial Update: Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin [NA]
A clinical trial studying isotopic distribution of intraperitoneal chemotherapy for peritoneal carcinomatosis of ovarian origin has been wit…
-
CLINICAL_TRIALS withdrawal · 2016-08-30Clinical Trial Update: Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating gum chewing to accelerate recovery of bowel function after abdominal surgery for endometrial and ovari…
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma [Phase 1]
A Phase 1 trial evaluating LDFWART in combination with docetaxel for platinum-resistant recurrent ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-26Clinical Trial Update: Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer [Phase 1]
A Phase 1 trial of talazoparib in combination with the HSP90 inhibitor AT13387 for metastatic advanced solid tumors and recurrent ovarian, f…
-
CLINICAL_TRIALS withdrawal · 2016-05-02Clinical Trial Update: Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations [Phase 3]
Phase 3 trial of olaparib maintenance versus placebo in platinum-sensitive relapsed ovarian cancer with sBRCAm or HRR gene mutations has bee…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating letrozole (Femara) versus placebo for ovarian, fallopian tube, or primary peritoneal cancer has been withdrawn.